Back

Association of CD44-/CD24- Breast Cancer Cells with Late Stage Tumor Recurrence

Liu, C.; Qiao, X.; Zhang, Y.; Sun, L.; Ma, Q.; Yang, J.; Ai, L.; Xue, J.; Chen, G.; Zhang, H.; Ji, C.; Gu, X.; Lei, H.; Yang, Y.

2020-12-07 physiology
10.1101/2020.12.07.414599 bioRxiv
Show abstract

Tumor metastasis remains the main cause of breast cancer-related deaths, especially the later breast cancer distant metastasis. This study assessed CD44-/CD24- tumor cells in 576 tissue specimens for associations with clinicopathological features and metastasis and then investigated the underlying molecular events. The data showed that level of CD44-/CD24- cells was associated with later postoperative distant tumor metastasis. Furthermore, CD44-/CD24- triple negative cells could spontaneously convert into CD44+/CD24- cancer stem cells (CSCs) with properties similar to CD44+/CD24- CSCs from parental MDA-MB-231 cells in terms of gene expression, tumor cell xenograft formation, and lung metastasis in vitro and in vivo. Single-cell RNA sequencing identified RHBDL2 as a regulator that enhanced spontaneous CD44+/CD24- CSC conversion, whereas knockdown of RHBDL2 expression inhibited YAP/NF-{kappa}B signaling and blocked spontaneous CD44-/CD24- cell conversion to CSCs. These data suggested that the level of CD44-/CD24- tumor cells could predict breast cancer prognosis, metastasis, and response to adjuvant therapy.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.